bristol-myers glp-1 receptor agonist products Five Unexpected New Uses for Agonists Market Overview: GLP-1 Agonists and
Description
Marzook A, Tomas A, Jones B
The two main incretins are GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide, previously called gastric inhibitory polypeptide)
A randomized trial compared effects on post-op hyperglycemia for patients receiving 0.5 mg subcutaneous liraglutide on the evening before surgery and 1.2 mg after induction of anesthesia or placebo
Author contributions QL: Conceptualization, Data curation, Formal analysis, Writing original draft, Writing review & editing
Compared with EX, the frequency of subcutaneous injection of LIXI is less, and the incidence of gastrointestinal adverse reactions and hypoglycemia is lower
Pharmacotherapy of obesity: an update on the available medications and drugs under investigation
